NASDAQ:PGNX Investor Alert: Lawsuit Filed in Effort to Halt the Takeover of Progenics Pharmaceuticals, Inc.
An investor, who currently holds shares of Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX), filed a lawsuit against the takeover of Progenics Pharmaceuticals, Inc.
View full press release